These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 3127582

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Follicular phase treatment of luteal phase defect with follicle-stimulating hormone in infertile women.
    Huang KE, Muechler EK, Bonfiglio TA.
    Obstet Gynecol; 1984 Jul; 64(1):32-6. PubMed ID: 6429590
    [Abstract] [Full Text] [Related]

  • 3. A short course of menotropin after clomiphene failure in infertile women with luteal phase defects.
    Wu CH.
    J Reprod Med; 1989 Oct; 34(10):807-10. PubMed ID: 2507780
    [Abstract] [Full Text] [Related]

  • 4. Menstrual disturbances in athletes: a focus on luteal phase defects.
    De Souza MJ.
    Med Sci Sports Exerc; 2003 Sep; 35(9):1553-63. PubMed ID: 12972877
    [Abstract] [Full Text] [Related]

  • 5. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG, Bourgain C, Kolibianakis E, Tournaye H, Devroey P.
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [Abstract] [Full Text] [Related]

  • 6. Unkei-to for correcting luteal phase defects.
    Ushiroyama T, Ikeda A, Higashio S, Hosotani T, Yamashita H, Yamashita Y, Suzuki Y, Ueki M.
    J Reprod Med; 2003 Sep; 48(9):729-34. PubMed ID: 14562640
    [Abstract] [Full Text] [Related]

  • 7. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernández V, Cano Trigo I, Gómez Parga JL, González Batres C, Rodríguez Escudero FJ.
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW, Byun HK, Yang KM, Song IO, Choi KH, Yoo KJ.
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Follicular phase treatment of luteal phase dysfunction.
    Dizerega GS, Hodgen GD.
    Fertil Steril; 1981 Apr; 35(4):428-32. PubMed ID: 6783446
    [Abstract] [Full Text] [Related]

  • 11. Luteal estrogen supplementation in pregnancies associated with low serum estradiol concentrations.
    Kaider AS, Coulam CB.
    Early Pregnancy (Cherry Hill); 2000 Jul; 4(3):191-9. PubMed ID: 11727011
    [Abstract] [Full Text] [Related]

  • 12. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A, David H, Libal Y, Ballas S.
    Harefuah; 1995 Dec 01; 129(11):455-6, 536. PubMed ID: 8846950
    [Abstract] [Full Text] [Related]

  • 13. Early follicular phase follicle-stimulating hormone treatment of endometrial luteal phase deficiency.
    Balasch J, Jové IC, Márquez M, Vanrell JA.
    Fertil Steril; 1990 Dec 01; 54(6):1004-7. PubMed ID: 2123158
    [Abstract] [Full Text] [Related]

  • 14. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
    Duffy DA, Manzi D, Benadiva C, Maier D, Saunders M, Nulsen J.
    Fertil Steril; 2006 Feb 01; 85(2):407-11. PubMed ID: 16595219
    [Abstract] [Full Text] [Related]

  • 15. Naltrexone in functional hypothalamic amenorrhea and in the normal luteal phase.
    Remorgida V, Venturini PL, Anserini P, Salerno E, De Cecco L.
    Obstet Gynecol; 1990 Dec 01; 76(6):1115-20. PubMed ID: 2122343
    [Abstract] [Full Text] [Related]

  • 16. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE, Hughes CL, Burger HG, Robertson DM, Fraser IS.
    Menopause; 2009 Dec 01; 16(1):50-9. PubMed ID: 18978637
    [Abstract] [Full Text] [Related]

  • 17. Hormonal characteristics in the early luteal phase of conceptive and nonconceptive menstrual cycles.
    Chen J, Qiu Q, Lohstroh PN, Overstreet JW, Lasley BL.
    J Soc Gynecol Investig; 2003 Jan 01; 10(1):27-31. PubMed ID: 12517590
    [Abstract] [Full Text] [Related]

  • 18. The efficacy of progesterone in achieving successful pregnancy: II. In women with pure luteal phase defects.
    Check JH, Adelson HG.
    Int J Fertil; 1987 Jan 01; 32(2):139-41. PubMed ID: 2883140
    [Abstract] [Full Text] [Related]

  • 19. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study.
    Demirol A, Gurgan T.
    Hum Reprod; 2007 Jan 01; 22(1):97-100. PubMed ID: 16954409
    [Abstract] [Full Text] [Related]

  • 20. Observations on the use of purified follicle-stimulating hormone in the treatment of luteal phase defects.
    Di Carlo C, Affinito P, Farace MJ, Gargiulo AR, Zullo F, Nappi C.
    Hum Reprod; 1995 Jun 01; 10(6):1359-62. PubMed ID: 7593496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.